Home › Funds › Ascentis Independent Advisors › GILD

Ascentis Independent Advisors position in GILD

GILEAD SCIENCES INC · Health Care

Ascentis Independent Advisors reported holding 69,262 shares of GILD (GILEAD SCIENCES INC) in its Q3 2026 13F filing — a position valued at US$10.3M, representing 0.61% of its reported portfolio and ranking #23 among its reported holdings. Ascentis Independent Advisors has disclosed GILD holdings in 6 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)69.26K sh
Reported value held$10.32M
Portfolio Weight0.61%
First reportedQ3 2023
Last changeAdd
Updated2026-11-04

Last updated: 2026-11-04 · Source: SEC EDGAR Form 13F-HR

How Ascentis Independent Advisors's GILD position evolved

Ascentis Independent Advisors first disclosed a stake in GILD in Q3 2023 at 2,829 shares (US$212K). The position peaked in Q3 2026 at 69,262 shares, worth US$10.3M. Across 6 filings, Ascentis Independent Advisors increased the stake 1 time(s), trimmed it 2 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 69,262 shares valued at US$10.3M — an increase of 68,559 shares quarter over quarter.. Notable position changes include a 99% trim in Q2 2026 (shares rose 18% over the following quarter), a 9752% increase in Q3 2026 (shares rose 12% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 2.83K $212.00K New
Q4 2023 2.56K $207.68K Reduce
Q3 2024 1.03K $86.67K New
Q1 2026 69.52K $9.69M New
Q2 2026 703 $88.81K Reduce
Q3 2026 69.26K $10.32M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About GILD and 13F data

GILD (GILEAD SCIENCES INC) is a Health Care company. 35 other funds we track also report a position in GILD — the largest reported positions include Fidelity Management & Research (FMR) (US$8.45B), Capital World Investors (US$5.18B), Capital World Investors (US$5.18B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding GILD

All GILD fund holders →

FAQ

How long has Ascentis Independent Advisors held GILD?

Ascentis Independent Advisors has disclosed GILD holdings in 6 of the last 13 reported quarters, going back to Q3 2023.

What is Ascentis Independent Advisors's current position in GILD?

As of Q3 2026, Ascentis Independent Advisors holds 69.26K shares of GILD (GILEAD SCIENCES INC), valued at $10.32M, representing 0.61% of its reported portfolio and ranking #23.

Has Ascentis Independent Advisors been buying or selling GILD?

In the latest 13F filing (Q3 2026), Ascentis Independent Advisors increased its position in GILD. The position peaked in Q3 2026 at 69.26K shares.

Which other funds hold GILD?

Other major institutional holders of GILD include Fidelity Management & Research (FMR), Capital World Investors, Capital World Investors, among 35 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.